Risks of Agranulocytosis and Aplastic Anemia: A First Report of Their Relation to Drug Use With Special Reference to Analgesics

JAMA: The Journal of the American Medical Association

Volumn 256, Issue 13, 1986, Pages 1749-1757

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENAZONE; ANALGESIC AGENT; BENZYDAMINE; CLONIXIN; DICLOFENAC; DIPYRONE; GLAFENINE; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NIFLUMIC ACID; OXYPHENBUTAZONE; PARACETAMOL; PHENAZONE; PHENYLBUTAZONE; PIROXICAM; PROQUAZONE; SALICYLIC ACID DERIVATIVE;

ADVERSE DRUG REACTION; AGRANULOCYTOSIS; APLASTIC ANEMIA; BLOOD AND HEMOPOIETIC SYSTEM; CONTROLLED STUDY; DRUG COMPARISON; DRUG THERAPY; EPIDEMIOLOGY; EUROPE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THERAPY;

ACETAMINOPHEN; ADULT; AGED; AGRANULOCYTOSIS; AMINOPYRINE; ANALGESICS; ANEMIA, APLASTIC; ANTIPYRINE; DIPYRONE; EUROPE; HUMAN; ISRAEL; MIDDLE AGE; PHENYLBUTAZONE; RISK; SALICYLATES; SUPPORT, NON-U.S. GOV'T;

EID: 0022508895     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1986.03380130077032     Document Type: Article

References (44)

1. Swanson R, Cook R: Drugs, Chemicals and Blood Dyscrasias. Hamilton, Ill, Drug Intelligence Publications, 1977
2. De Gruchy GC: Drug-Induced Blood Disorders. Oxford, Blackwell Scientific Publications, 1975.
3. Girdwood RH (ed): Blood Disorders due to Drugs and Other Agents. Amsterdam, Excerpta Medica, 1974.
4. Heimpel H, Heit W: Drug-induced aplastic anemia: Clinical aspects. Clin Hematol 1980;9:641-662.
5. The International Agranulocytosis and Aplastic Anemia Study: The design of a study of the drug etiology of agranulocytosis and aplastic anemia. Eur J Clin Pharmacol 1983;24:833-836.
6. Miettinen OS: The ‘case-control’ study: Valid selection of subjects. J Chronic Dis 1985;38:543-549.
7. Portnoy B, Hanes B, Salvatore MA, et al.: The peripheral white blood count in respirovirous infection. J Pediatr 1966;88:181.
8. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies. JNCI 1959;22:719-748.
9. Miettinen OS: Estimability and estimation in case referent studies. Am J Epidemiol 1976; 103:226-235.
10. Armitage P: Statistical Methods in Medical Research. New York, John Wiley & Sons Inc, 1971, pp 380-384.
11. Miettinen OS: Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974;99:325-332.
12. Discombe G: Agranulocytosis caused by amidopyrine: An avoidable cause of death. Br Med J 1952;1:1270-1273.
13. Huguley CH: Agranulocytosis induced by dipyrone, a hazardous antipyretic and analgesic. JAMA 1964;189:938-941.
14. Madison FW, Squier TL: Etiology of primary granulocytopenia (agranulocytic angina). JAMA 1934;102:755.
15. Moeschlin S, Wagner K: Agranulocytosis due to the occurrence of leukocyte-agglutinins. Acta Haematol 1952;8:29.
16. Moeschlin S: Leucocyte-autoantibodies. Acta Haematol 1958;20:167.
17. Palva IP, Mustala OO: Drug-induced agranulocytosis with special reference to aminophenazone: I. Adults. Acta Med Scand 1970;187:109-115.
18. Westerholm B, Reizenstein P: Drug-induced agranulocytosis, in Baker SB (ed): Correlation of Adverse Effects in Man With Observations in Animals. Amsterdam, Excerpta Medica, 1971, vol 220, pp 217-221.
19. Kantero I, Mustala OO, Palva IP: Druginduced agranulocytosis with special reference to aminophenazone: IV. Children. Acta Med Scand 1972;192:327-330.
20. Böttiger LE, Westerholm B: Drug-induced blood dyscrasias in Sweden. Br Med J 1973; 3:339-343.
21. Böttiger LE, Westerholm B: Drug-induced blood dyscrasias. Acta Med Scand 1979;205:457-461.
22. Böttiger LE, Böttiger B: Incidence and cause of aplastic anemia, hemolytic anemia, agranulocytosis and thrombocytopenia. Acta Med Scand 1981;210:475-479.
23. Arylalkonic acid nonsteroidal antiinflammatory drugs (ibuprofen, fenoprofen, naproxen, tolmetin, sulindac, indomethacin): Suspected new, rare or serious adverse drug reactions reported to the division of drug experience: Aplastic anemia, agranulocytosis, thrombocytopenia, in ADR High-lights. Food and Drug Administration, 1980.
24. Israels MCG: Drug agranulocytosis and marrow aplasia. Proc R Soc Med 1962;55:36.
25. Ruvidic R, Jelic S: Haematological aspects of drug-induced agranulocytosis. Scand J Haematol 1972;9:18-27.
26. Magis CC, Thierfelder S, Saint-Paul M, et al.: Etude serologique d'une agranulocytose allergique a l'amidopyrine. Nouv Rev Fr Hematol 1962; 2:602.
27. Catalogo de Especialidades Farmaceuticas. Madrid, Consejo General de Colegios Oficiales de Farmaceuticos, 1981, p 1570.
28. Catalogo de Especialidades Farmaceuticas. Madrid, Consejo General de Colegios Oficiales de Farmaceuticos, 1983, p 1287.
29. Yosselson-Superstine S: Handbook of Drug Information and Consultation. Jerusalem, The Magnes Press, 1980.
30. Utmutato a Gyogyszerkeszitmenyek Rendelesere. Budapest, Medicina Kônyukiado, 1980.
31. Nordic Statistics on Medicines, 1975-1977, Part II. Uppsala, Sweden, Nordic Council on Medicines, 1978, pp 17-23.
32. Shapiro S: Agranulocytosis and pyrazolone. Lancet 1984;1:1471.
33. Gross R, Horstmann H, Vogel J, et al.: Zur Epidemiologie und Klinik der medikamentosallergischen Agranulozytose. Med Welt 1967; 31:1767-1779.
34. Varonos DD, Santamouris S, Karambali S: The incidence of dipyrone-induced agranulocytosis in Greece during 1975. J Int Med Res 1979; 7:564-568.
35. Böttiger LE, Westerholm B: Aplastic anemia: I. Incidence and aetiology. Acta Med Scand 1972; 192:315-318.
36. Inman WH: Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br Med J 1977;1:1500-1505.
37. Canada AT Jr: Aplastic anemia after indomethacin. N Engl J Med 1968;278:743.
38. Frederick GR, Tanaka KR: Indomethacin and aplastic anemia. N Engl J Med 1968;279:1290.
39. Porzsolt F, Asbeck F, Heit W, et al.: Panmielopathie nach Einnahme von Diclofenac. Dtsch Med Wochenschr 1979;104:986-987.
40. Aoki K, Fujiki M, Shumiza H, et al.: Geographic and ethnic differences of aplastic anemia in humans, in Najean Y (ed): Medullary Aplasia. New York, Masson Publishers USA Inc, 1980, pp 79-89.
41. Szklo M, Sensenbrenner L, Markowitz J, et al.: Incidence of aplastic anemia in metropolitan Baltimore: A population-based study. Blood 1985; 66:115-119.
42. Allan R, Dykes P: A study of the factors influencing mortality rates from gastrointestinal hemorrhage. Q J Med 1976;45:533.
43. Levy M: Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease. N Engl J Med 1984;290:1158-1162.
44. Coggon D, Langman MJS, Spiegelhalter D: Aspirin, paracetamol and haematemesis and melena. Gut 1982;23:340-344.